R&D and Clinical departments, Pendulum Therapeutics, Inc, San Francisco, CA, USA.
Gut Microbes. 2021 Jan-Dec;13(1):1-28. doi: 10.1080/19490976.2021.1907272.
is a butyrate-producing human gut symbiont that has been safely used as a probiotic for decades. strains have been investigated for potential protective or ameliorative effects in a wide range of human diseases, including gut-acquired infection, intestinal injury, irritable bowel syndrome, inflammatory bowel disease, neurodegenerative disease, metabolic disease, and colorectal cancer. In this review we summarize the studies on supplementation with special attention to proposed mechanisms for the associated health benefits and the supporting experimental evidence. These mechanisms center on molecular signals (especially butyrate) as well as immunological signals in the digestive system that cascade well beyond the gut to the liver, adipose tissue, brain, and more. The safety of probiotic strains appears well-established. We identify areas where additional human randomized controlled trials would provide valuable further data related to the strains' utility as an intervention.
是一种产生丁酸盐的人类肠道共生菌,几十年来一直被安全地用作益生菌。人们研究了该菌株在多种人类疾病中的潜在保护或改善作用,包括肠道获得性感染、肠道损伤、肠易激综合征、炎症性肠病、神经退行性疾病、代谢性疾病和结直肠癌。在这篇综述中,我们总结了关于补充的研究,特别关注与相关健康益处相关的拟议机制和支持性实验证据。这些机制集中在分子信号(特别是丁酸盐)以及消化系统中的免疫信号上,这些信号不仅在肠道内传递,还传递到肝脏、脂肪组织、大脑等更远的部位。益生菌 菌株的安全性似乎已经得到很好的确立。我们确定了在哪些领域需要进行更多的人类随机对照试验,以提供与该菌株作为干预措施的效用相关的有价值的进一步数据。